Guinness Atkinson Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-62,949
Closed -$4.03M 106
2023
Q2
$4.03M Sell
62,949
-1,498
-2% -$100K 2.13% 25
2023
Q1
$4.47M Sell
64,447
-1,366
-2% -$96.3K 2.52% 20
2022
Q4
$4.74M Sell
65,813
-3,307
-5% -$249K 2.98% 13
2022
Q3
$4.91M Hold
69,120
3.14% 9
2022
Q2
$5.32M Sell
69,120
-44,555
-39% -$3.39M 3.1% 9
2022
Q1
$8.3M Sell
113,675
-2,282
-2% -$153K 3.99% 2
2021
Q4
$7.23M Sell
115,957
-3,230
-3% -$189K 3.16% 16
2021
Q3
$7.05M Buy
119,187
+10,167
+9% +$670K 3.28% 18
2021
Q2
$7.29M Hold
109,020
3.23% 19
2021
Q1
$6.88M Buy
109,020
+13,590
+14% +$846K 3.4% 13
2020
Q4
$5.92M Buy
95,430
+12,500
+15% +$769K 3.17% 21
2020
Q3
$5M Hold
82,930
3.04% 21
2020
Q2
$4.88M Hold
82,930
3.15% 20
2020
Q1
$4.62M Sell
82,930
-11,770
-12% -$719K 3.66% 14
2019
Q4
$6.08M Buy
+94,700
New +$5.42M 4.29% 12

Other funds holding BMY

Guinness Atkinson Asset Management's BMY Position: Q3 2023 in Review

Guinness Atkinson Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 62,949 shares — an estimated $4.03M sold.

Guinness Atkinson Asset Management first reported a position in BMY in Q4 2019 and held it in 15 quarters. The position peaked at $8.3M in Q1 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Guinness Atkinson Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Guinness Atkinson Asset Management sold 62,949 Bristol-Myers Squibb shares in Q3 2023, an estimated $4.03M.
  • Guinness Atkinson Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 15 quarters.
  • Guinness Atkinson Asset Management's Bristol-Myers Squibb position peaked at $8.3M in Q1 2022.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Guinness Atkinson Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.